WebDhan Chand is a Scientific Director, Head of Drug Discovery at Agenus based in Lexington, Massachusetts. Previously, Dhan was a Graduate Research Assistant and Project Co-leader at University of Toronto. WebApr 6, 2024 · Agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. ... Jennifer Buell and Dr. Dhan Chand will …
The TIGIT Pathway: A Deep Dive in Cancer …
WebHear Dhan Chand, Agenus head of drug discovery, discuss #TIGIT at the TIGIT summit today! Dhan speaks about the importance of Fc enhancement for TIGIT… WebOct 5, 2024 · Separately, Agenus announced today that Dhan Chand, PhD, Head of Drug Discovery at Agenus was selected to present on the topic of enhanced CTLA-4 blockade at the SITC Targets for Cancer IO Deep Dive Series on Wednesday, October 5, … rb battles toh
Our Next Wave of Innovation - Agenus Inv. Day 2024 on Vimeo
WebSenior Scientific Director, Head of Drug Discovery, Agenus Inc. - Cited by 414 - Cancer Immunology - Cell and Molecular Biology - Neuroscience - Endocrinology ... Dhan Chand. Senior Scientific Director, Head of Drug Discovery, Agenus … WebNov 8, 2024 · Agenus (AGEN 0.68%) Q3 2024 Earnings Call ... So let me ask Dhan Chand, who is also here, to give you a very brief rationale based on extensive preclinical data, as well as the data from a similar ... WebNov 13, 2024 · Dr. Jennifer Buell and Dr. Dhan Chand of Agenus will be available to discuss the next steps for AGEN1181 and indications selected for expansion. They will also discuss data from other programs ... rb battles super golf badge